A SWITCH TO DOLUTEGRAVIR IN COMBINATION WITH BOOSTED DARUNAVIR IS SAFE AND
EFFECTIVE IN SUPPRESSED PATIENTS WITH HIV - A SUBANALYSIS OF THE DUALIS STUDY
Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), July 21-24, 2019, Mexico City
